Wroclaw Medical University
Welcome,         Profile    Billing    Logout  
 14 Trials 
15 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lesiak, Maciej
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Recruiting
4
3010
Europe
P2Y12 inhibitor, Aspirin, DOAC
Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor
09/26
12/26
NCT03022851: The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

Recruiting
N/A
30
Europe, RoW
Occlutech AFR Device
Occlutech International AB
Pulmonary Hypertension
02/23
12/23
CAPTURE2, NCT03892824: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

Active, not recruiting
N/A
100
Europe, RoW
Vine™ Embolic Protection System
Javelin Medical, Genae
Atrial Fibrillation, Stroke
11/22
10/24
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30
Teles, Rui
NCT04703699: Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.

Recruiting
N/A
200
Europe, RoW
Myval Transcatheter Heart Valve Series, Myval THV
Meril Life Sciences Pvt. Ltd.
Aortic Valve Stenosis
05/24
11/28
NCT03424941: The TransCatheter Valve and Vessels Trial

Completed
N/A
172
Europe
FFR-guided PCI and TAVI, CABG and SAVR
Maatschap Cardiologie Zwolle, Medtronic
Aortic Stenosis, Multi Vessel Coronary Artery Disease, TAVI, CABG, PCI, Fractional Flow Reserve
06/24
06/24
NCT05601453: The ReTAVI Prospective Observational Registry

Recruiting
N/A
150
Europe, Canada, RoW
Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve
Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences
Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure
09/25
12/26
VISTA, NCT06008080: Post-Market Clinical Follow Up Study with Navitor Valve

Recruiting
N/A
1000
Europe, Japan
Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading System
Abbott Medical Devices
Aortic Stenosis
01/26
12/30
Stawarski, Andrzej
NCT04779320 / 2020-004301-31: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting
3
120
Europe, Canada, Japan, US, RoW
Vedolizumab IV, ENTYVIO, KYNTELES, MLN0002
Takeda, Takeda Development Center Americas, Inc.
Crohn's Disease (CD)
11/24
11/24
MLN0002-3024, NCT04779307 / 2020-004300-34: A Study of Vedolizumab in Children and Teenagers with Moderate to Severe Ulcerative Colitis (UC)

Active, not recruiting
3
121
Europe, Canada, Japan, US, RoW
Vedolizumab, MLN0002, ENTYVIO, KYNTELES
Takeda, Takeda Development Center Americas, Inc.
Colitis, Ulcerative
08/25
08/25
Szulc, Małgorzata
SCALP2, NCT05914805: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Recruiting
3
726
Europe, US
Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle
Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research
Alopecia, Androgenetic
08/24
03/25
Protasiewicz, Marcin
LANDMARK, NCT04275726: Trial: a Randomised Controlled Trial of Myval THV

Recruiting
N/A
768
Europe, RoW
Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site.
Meril Life Sciences Pvt. Ltd.
Aortic Valve Stenosis
03/24
12/33
NCT05601453: The ReTAVI Prospective Observational Registry

Recruiting
N/A
150
Europe, Canada, RoW
Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve
Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences
Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure
09/25
12/26
Biegus, Jan
FASTR-EU, NCT06362668: EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System

Recruiting
N/A
30
Europe
Reprieve Decongestion Management System, Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide)
Reprieve Cardiovascular, Inc
Acute Decompensated Heart Failure
10/24
12/24
DELTA-HF, NCT05747196: The Safety and Feasibility of the eLym™ System

Recruiting
N/A
50
Europe, RoW
WhiteSwell eLym System
WhiteSwell, Limited
Heart; Decompensation, Congestive
06/25
12/25
Zimoch, Wojciech
No trials found
Drozd, Jakub
No trials found
Bardowska, Klaudia
No trials found

Download Options